11 Best and Cheap Stocks to Buy Right Now
On October 3, Wharton professor and WisdomTree Chief Economist Jeremy Siegel joined CNBC for an interview to discuss the current and near-future outlook for the stock market.
Pfizer Inc (PFE)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 48,390,268 | $1,172,980,101 | +3% | 0.47% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 18,718,955 | $453,747,469 | +44% | 0.32% |
| 3. | Diamond Hill Capital Ric Dillon | 17,664,353 | $428,183,917 | -6% | 1.97% |
| 4. | 15,977,200 | $387,287,328 | -19% | 0.07% | |
| 5. | Citadel Investment Group Ken Griffin | 14,866,203 | $360,356,761 | +112% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.65 | 19,457 | $499,072.05 | 27,707 | 2025-02-13 | Filing | |
| $28.24 | 1,000 | $28,240.00 | 10,000 | 2024-10-30 | Filing | |
| $26.47 | 3,000 | $79,401.00 | 9,000 | 2023-12-15 | Filing | |
| $38.58 | 1,000 | $38,580.00 | 6,000 | 2023-05-08 | Filing | |
| $38.43 | 1,000 | $38,425.00 | 5,000 | 2023-05-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.93 | 2,500 | $64,825.00 | 11,850 | 2025-03-04 | Filing | |
| $28.66 | 5,154 | $147,713.64 | 8,582 | 2024-08-13 | Filing | |
| $40.02 | 9,912 | $396,678.24 | 9,003 | 2023-03-15 | Filing | |
| $53.96 | 4,218 | $227,603.28 | 10,846 | 2022-06-07 | Filing | |
| $50.50 | 4,000 | $202,000.00 | 15,064 | 2022-05-16 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 166,765 | $4,249,164 | 0.36% | |
| 2. | 120,211 | $3,062,976 | 0.61% | |
| 3. | 109,430 | $2,788,274 | 0.12% | |
| 4. | 100,112 | $2,550,865 | 1.74% | |
| 5. | 89,743 | $2,441,895 | 0.38% |
News See All
Cantor Fitzgerald Maintains a Hold on Pfizer (PFE)
Pfizer Inc. (NYSE:PFE) is one of the best medical stocks to buy now. In a report released on September 29, Carter Gould from Cantor Fitzgerald maintained a Hold rating on Pfizer Inc.
BMO Capital Maintains Outperform on Pfizer (PFE) Amid New Obesity Partnership
Pfizer Inc. (NYSE:PFE) ranks among the top picks for a retirement portfolio. BMO Capital reaffirmed its Outperform rating and $30 price target for Pfizer Inc.
Pfizer (PFE): A Healthcare Giant Offering Steady Dividend Income
Pfizer Inc. (NYSE:PFE) is a US pharmaceutical and biotech giant that provides various allied products and services to its customers.
Retirement Stock Portfolio: Top 15 Stock Picks
The Federal Reserve is decreasing its benchmark rate after holding them stable for most of the year despite President Donald Trump's demands to do so.
Bank of America Securities Maintains a Neutral Stance on Pfizer Inc. (PFE)
Pfizer Inc. (NYSE:PFE) is one of the best large cap value stocks to buy now. On September 23, Bank of America Securities analyst Tim Anderson maintained a neutral stance on Pfizer Inc.
10 Highest Dividend-Paying Stocks to Buy in the S&P 500
If you’re an investor drawn to dividends, chasing the highest yields can be a risky game. Sure, a fat yield grabs attention, but honestly, that’s often just a sign the stock’s been hammered.
11 Best Large Cap Value Stocks to Buy Now
On September 26, Jeremy Siegel, Wharton professor emeritus and WisdomTree senior economist, appeared on CNBC's ‘Closing Bell’ to talk about the latest PCE report, whether the Fed should deemphasize...
Pfizer Inc. (PFE): A Bull Case Theory
We came across a bullish thesis on Pfizer Inc. on Investing With Purpose’s Substack. In this article, we will summarize the bulls’ thesis on PFE.